Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Net Cash Flow (2020 - 2025)

iSpecimen has reported Net Cash Flow over the past 6 years, most recently at $4.1 million for Q4 2025.

  • Quarterly results put Net Cash Flow at $4.1 million for Q4 2025, up 3138.2% from a year ago — trailing twelve months through Dec 2025 was $5.0 million (up 1175.53% YoY), and the annual figure for FY2025 was $5.0 million, up 1175.19%.
  • Net Cash Flow for Q4 2025 was $4.1 million at iSpecimen, up from $2.2 million in the prior quarter.
  • Over the last five years, Net Cash Flow for ISPC hit a ceiling of $17.9 million in Q4 2021 and a floor of -$11.5 million in Q1 2023.
  • Median Net Cash Flow over the past 5 years was -$388645.5 (2023), compared with a mean of -$500666.8.
  • Peak annual rise in Net Cash Flow hit 6967.86% in 2021, while the deepest fall reached 888.48% in 2021.
  • iSpecimen's Net Cash Flow stood at $17.9 million in 2021, then crashed by 129.8% to -$5.3 million in 2022, then soared by 92.94% to -$377902.0 in 2023, then soared by 133.49% to $126554.0 in 2024, then skyrocketed by 3138.2% to $4.1 million in 2025.
  • The last three reported values for Net Cash Flow were $4.1 million (Q4 2025), $2.2 million (Q3 2025), and -$192234.0 (Q2 2025) per Business Quant data.